PRMT5 and breast cancer: Moreover, studies have indicated that tamoxifen induces PRMT5 translocation to the nucleus in tamoxifen-sensitive cells, with higher nuclear PRMT5 levels associated with improved survival in luminal breast cancer cells [27,47].